The Impact of the COVID-19 Pandemic on Global Sourcing of Medical Supplies

Main Article Content

Senay Agca John Birge Jing Wu


We provide evidence that the COVID-19 pandemic has incentivized U.S. firms to rebalance the trade-off between manufacturing cost efficiency and supply chain resilience in their sourcing decisions. Over the past few decades, companies have been outsourcing production to low-cost countries such as China in pursuit of cost-efficiency. However, the risk of supply chain disruptions has been receiving heightened attention recently, as countries strive to prioritize scarce resources for domestic needs during the global pandemic. Our research shows that while China’s supply chain has proved resilient, U.S. companies have increased their access to medical supplies through domestic production. As a result, COVID-19 has highlighted the importance of local capacity and changed the traditional perception of outsourcing from a purely economic efficiency focus to one emphasizing the need to balance risks in global exposures.

Article Details

How to Cite
AGCA, Senay; BIRGE, John; WU, Jing. The Impact of the COVID-19 Pandemic on Global Sourcing of Medical Supplies. Medical Research Archives, [S.l.], v. 10, n. 9, sep. 2022. ISSN 2375-1924. Available at: <>. Date accessed: 23 may 2024. doi:
Research Articles


[1] Porter Michael E. What is Strategy? Harvard Business Review. 1996;74:61–78.
[2] Hertzel Michael G, Peng Jie, Wu Jing, Zhang Yu. Global supply chains and cross-border financing Available at SSRN 3289212. 2018.
[3] PWC . Sourcing and logistics in China. Costs, processes and strategies of German companies procuring in the Chinese market sourcing and logistics in china v2.pdf 2008.
[4] QIMA . Global Sourcing in 2022: Uncertainty the New Norm q2-barometer-uncertainty-new-norm 2022.
[5] Corbett Michael. The Outsourcing Revolution: Why It Makes Sense and How to Do It Right. Dearborn Trade Publishing first ed. 2004.
[6] Norman Jonas. THE HOLLOW CORPORATION. (cover story). BusinessWeek. 1986:57 - 59.
[7] Wong Alison. China Imposes New Export Restrictions for COVID-19 Medical Products 2020.
[8] Liu Luffy. 700 Tech Companies in China Have Begun Making Masks tech-companies-in-china-have-begun-making-masks/ 2020.
[9] Tian Ying. Chinese automakers produce face masks to fight coronavirus https: // coronavirus 2020.
[10] Cerullo Megam. Mask makers work overtime in China to meet spike in demand 2020.
[11] Andres B. Schwarzenberg Karen M. Sutter. Medical Supply Chains and Policy Options: The Data Challenge 2020.
[12] Agca Senay, Babich Volodymyr, Birge John R, Wu Jing. Credit shock propagation along supply chains: Evidence from the CDS market Management Science. 2021.
[13] Charoenwong Ben, Han Miaozhe, Wu Jing. Trade and Foreign Economic Policy Uncertainty in Supply Chain Networks: Who Comes Home? Manufacturing & Service Operations Management. 2022.
[14] Agca Senay, Birge John R, Wang Zi’ang, Wu Jing. The impact of COVID-19 on supply chain credit risk Available at SSRN 3639735. 2020.
[16] Kaplan Deborah Abrams. Developing the coronavirus vaccine supply chain 2020.
[17] Dzhanova Yelena. Trump compelled these companies to make critical supplies, but most of them were already doing it 2020.
[18] White Joseph. GM, Ford coronavirus U.S. ventilator projects close in on their finish lines 2020.
[19] Molina Brett. Elon Musk says Tesla is working on ventilators for coronavirus patients but doubts there will be a shortage 2020